naija questions
Moderator
(HealthDay News) — A personalized vaccine held an aggressive group of cancers in check among more than half of patients who received it in a small, preliminary trial, researchers report. HER2-positive cancers …
Read more via WebMD Health https://ift.tt/2y3xTXV
Read more via WebMD Health https://ift.tt/2y3xTXV
Last edited by a moderator: